Even today, for understudied populations like Black women whose age-adjusted prevalence of preeclampsia can exceed 12%, the question of preeclampsia’s potential protective effect on later life breast cancer incidence remains incomplete, as these studies have not accounted for IGF1R rs2016347 genotype differences [1]. The gene discussed is IGF1R; the disease is breast cancer.